Name: Sphingolipid Metabolism and Metabolic Disease (en Inglés)
Price: 636233.00 COP
Availability: InStock
Author: Jiang, Xian-Cheng
ISBN: 9789811903960

portada Sphingolipid Metabolism and Metabolic Disease (en Inglés)

Sphingolipid Metabolism and Metabolic Disease (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Jiang, Xian-Cheng

Idioma

Inglés

N° páginas

213

Encuadernación

Tapa Blanda

ISBN13

9789811903960

Categorías

Investigación médica
Enfermedades y trastornos

Sphingolipid Metabolism and Metabolic Disease (en Inglés)

Jiang, Xian-Cheng (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 23 a 30 días háb.

$ 1.060.389$ 636.233

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 636.233

¡Envío Gratis! Llega entre el 23 Jul y el 04 Ago a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Sphingolipid Metabolism and Metabolic Disease (en Inglés)"

This book provides an up-to-date review of the fundamentals of sphingolipid metabolism and its role in metabolic diseases. Focusing on the sphingolipid de novo synthesis pathway, the effect of sphingomyelin, ceramide, and sphingosine-1-phosphate, and linkage between sphingolipids and other lipids, such as cholesterol, it covers serine palmitoyltransferase, ceramide synthases, ceramidases, sphingosine kinases, and sphingomyelin synthases, and more. While highlighting how rare diseases related to abnormal glycosphingolipid metabolism, this publication introduces sphingolipid metabolism-related diseases, such as lung diseases and cancers, as well as sphingolipid circadian regulation. The book demonstrates advances and limitations of research on sphingolipid metabolism and its roles in metabolic diseases and other diseases. It offers graduate students and researchers a coherent overview of sphingolipids, as well as the limitations of current research in the field, and promotes further studies on metabolic diseases, as well as pharmaceutical research on drug discovery based on sphingolipid de novo synthase.